Fridrik Thor Sigurbjörnsson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Leukocytapheresis is a controversial nonpharmacologic treatment for IBD, in which white blood cells—the effector cells of the inflammatory process—are mechanically removed from the circulation. Current controversy centers on the uncontrolled nature of the leukocytapheresis trials performed and their use of different outcome measures in patient groups that(More)
  • 1